News
Russia Says Its Sputnik V COVID-19 Vaccine 95% Effective
Russia's Sputnik V coronavirus vaccine is 95 percent effective according to a second interim analysis of clinical trial data, its developers said on Tuesday....
News
Government of Canada signs new agreement for a COVID-19 antibody therapy
The Government of Canada is taking steps to provide Canadians with effective therapies as part of its response to COVID-19. The Honourable Anita Anand,...
News
Regeneron’s REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA EUA
Regeneron Pharmaceuticals, Inc. announced that the antibody cocktail casirivimab and imdevimab administered together (also known as REGN-COV2 or REGEN-COV2), a therapy currently being investigated...
Drug Research
CureVac and WACKER Sign Manufacturing Contract for CureVac’s COVID-19 Vaccine Candidate
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Wacker Chemie AG announced that...
Press Releases
Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations
Baxter International Inc. has announced a $50 million expansion of its sterile fill/finish manufacturing facilities located in Bloomington, IN. These facilities are operated by...
Clinical Trials
Astrazeneca Says AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in...
Articles
Providing India with Better Access to Affordable, Effective COPD Treatments
Capsule-based dry powder inhalers are making treating conditions of the lung, safe, effective and patient-centered
Between 1990 and 2017, Chronic Obstructive Pulmonary Disease (COPD) was...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read